Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ludmila Sebejova"'
Autor:
Emilie Lukášová, Martina Řezáčová, Alena Bačíková, Ludmila Šebejová, Jiřina Vávrová, Stanislav Kozubek
Publikováno v:
FEBS Open Bio, Vol 9, Iss 5, Pp 870-890 (2019)
Replication stress (RS) is a major driver of genomic instability and tumorigenesis. Here, we investigated whether RS induced by the nucleotide analog fludarabine and specific kinase inhibitors [e.g. targeting checkpoint kinase 1 (Chk1) or ataxia tela
Externí odkaz:
https://doaj.org/article/c563f6f53d56495781761a7986de7d6a
Autor:
Klara Mareckova, Anna Pacinkova, Radek Marecek, Ludmila Sebejova, Lydie Izakovicova Holla, Jana Klanova, Milan Brazdil, Yuliya S. Nikolova
Publikováno v:
Frontiers in Aging Neuroscience, Vol 15 (2023)
IntroductionThe proportion of older adults within society is sharply increasing and a better understanding of how we age starts to be critical. However, given the paucity of longitudinal studies with both neuroimaging and epigenetic data, it remains
Externí odkaz:
https://doaj.org/article/0ed6036ef6e548e3a1fe1253132c0ce0
Autor:
Veronika Navrkalova, Ludmila Sebejova, Jana Zemanova, Jana Kminkova, Blanka Kubesova, Jitka Malcikova, Marek Mraz, Jana Smardova, Sarka Pavlova, Michael Doubek, Yvona Brychtova, David Potesil, Veronika Nemethova, Jiri Mayer, Sarka Pospisilova, Martin Trbusek
Publikováno v:
Haematologica, Vol 98, Iss 7 (2013)
ATM abnormalities are frequent in chronic lymphocytic leukemia and represent an important prognostic factor. Sole 11q deletion does not result in ATM inactivation by contrast to biallelic defects involving mutations. Therefore, the analysis of ATM mu
Externí odkaz:
https://doaj.org/article/7151e415765547daba8ee5a8ed2e6964
Publikováno v:
American Journal of Hematology
Autor:
Michael, Doubek, Yvona, Brychtova, Anna, Panovska, Ludmila, Sebejova, Olga, Stehlikova, Jana, Chovancova, Jitka, Malcikova, Jana, Smardova, Karla, Plevova, Pavlina, Volfova, Martin, Trbusek, Marek, Mraz, Denisa, Bakesova, Jakub, Trizuljak, Marketa, Hadrabova, Petra, Obrtlikova, Josef, Karban, Lukas, Smolej, Alexandra, Oltova, Eva, Jelinkova, Sarka, Pospisilova, Jiri, Mayer
Publikováno v:
American Journal of Hematology. 90(5):417-421
The treatment of relapsed/refractory chronic lymphocytic leukemia (CLL) remains a challenging clinical issue. An important treatment option is the use of high-dose corticosteroids. The purpose of this clinical trial was to determine the efficacy and